Colorectal Cancer | Topics

 
Promising Preliminary Data for KRAS G12C Inhibition With Adagrasib Are Presented for CRC
September 19, 2021

Data from the KRYSTAL-1 trial show promise of adagrasib as monotherapy and in combination with other standard agents for colorectal cancer.

The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform
September 15, 2021

Patients with colorectal cancer could benefit from the COLMATE platform as it allows for opportunities in clinical trial enrollment.

Onvansertib Plus Standard-of Care-Chemotherapy Meet Primary End Point of ORR in Metastatic Colorectal Cancer
September 09, 2021

The use of onvansertib in combination with standard-of-care chemotherapy had an increase in the objective response rate and progression-free survival during the phase 1b/2 trial for metastatic colorectal cancer.